By continuing to browse our website, you agree to the storing of first- and third-party cookies and related technologies on your device to enhance site access and navigation, analyze site usage, authenticate users, facilitate transactions, and assist in our marketing efforts. Please read our privacy notice to learn more.

Buffett Cancer Center uses new treatment to better target certain tumors

UNMC is now utilizing Lutathera, a new molecular therapy for neuroendocine tumors. This was featured on Channel 3 News:

And via a Nebraska Medicine video:

twitter facebook bluesky email print